METROPOLITAN LIFE INSURANCE CO/NY - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$61,120
+94.9%
1,6510.0%0.00%
+200.0%
Q2 2022$31,352
-29.6%
1,6510.0%0.00%
-50.0%
Q1 2022$44,560
-57.6%
1,651
-64.6%
0.00%
+100.0%
Q4 2021$105,080
-14.0%
4,6640.0%0.00%
-50.0%
Q3 2021$122,243
-18.1%
4,6640.0%0.00%0.0%
Q2 2021$149,295
-9.1%
4,6640.0%0.00%0.0%
Q1 2021$164,219
+9.8%
4,6640.0%0.00%0.0%
Q4 2020$149,574
-14.8%
4,6640.0%0.00%
-33.3%
Q3 2020$175,460
-15.9%
4,6640.0%0.00%
-25.0%
Q2 2020$208,7144,6640.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 2,270,072$61,269,0009.93%
GREAT POINT PARTNERS LLC 790,000$21,322,0005.15%
ACUTA CAPITAL PARTNERS, LLC 342,000$9,231,0004.31%
COWEN AND COMPANY, LLC 1,164,361$31,426,0003.02%
Altium Capital Management LP 206,000$5,560,0001.86%
BVF INC/IL 1,647,400$44,463,0001.78%
RTW INVESTMENTS, LP 2,540,074$68,557,0001.42%
Vivo Capital, LLC 705,882$19,052,0001.31%
RA Capital Management 2,000,000$53,980,0001.18%
SPHERA FUNDS MANAGEMENT LTD. 291,252$7,861,0001.11%
View complete list of RELMADA THERAPEUTICS INC shareholders